ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,930,000 | +81.9% | 47,423 | +14.4% | 0.05% | +73.3% |
| Q3 2014 | $1,611,000 | +31.3% | 41,463 | +16.6% | 0.03% | +36.4% |
| Q2 2014 | $1,227,000 | -29.3% | 35,561 | -11.5% | 0.02% | -33.3% |
| Q1 2014 | $1,735,000 | +71.4% | 40,175 | +57.8% | 0.03% | +94.1% |
| Q4 2013 | $1,012,000 | +14.2% | 25,461 | +8.0% | 0.02% | 0.0% |
| Q3 2013 | $886,000 | +75.4% | 23,565 | +25.4% | 0.02% | +54.5% |
| Q2 2013 | $505,000 | – | 18,785 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,976,526 | $368,991,000 | 11.95% |
| HWG Holdings LP | 155,584 | $9,606,000 | 6.84% |
| DOWLING & YAHNKE LLC | 676,313 | $41,756,000 | 5.20% |
| Ghost Tree Capital, LLC | 150,000 | $9,261,000 | 4.44% |
| WILLIAM HARRIS INVESTORS INC | 276,870 | $17,094,000 | 4.41% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 61,225 | $3,780,000 | 2.87% |
| Opus Point Partners Management, LLC | 45,418 | $2,804,000 | 2.77% |
| PINNACLE ASSOCIATES LTD | 1,917,838 | $118,407,000 | 2.32% |
| Ghost Tree Capital, LLC | 50,000 | $3,087,000 | 1.48% |
| Adamant Biomedical Investments AG | 100,000 | $6,174,000 | 1.48% |